European drugmakers on Monday announced a trio of deals around a billion dollars each to buy U.S.-listed biopharmas at hefty premiums. Anglo-Swedish AstraZeneca AZN, +1.42% AZN, -1.26% said it’s pay...
Tag: AZN
LogicBio’s stock skyrockets after buyout bid for a 667% premium
Shares of LogicBio Therapeutics Inc. LOGC, +644.44% skyrocketed more than seven-fold (up 643%) in morning trading, to bounce off the previous session’s record low, after the genetic medicine com...
Gilead’s stock is up about 4% after sharing new data for cancer drug
Shares of Gilead Sciences Inc. GILD, +5.16% were up 4.9% in trading on Monday after the company said in a news release that Trodelvy improved overall survival rates in people with HR+/HER2- metastatic...